About the Bristol Myers of Buspirone – Buspar
|
|
|
|
|
|
| About the Manufacturer of
Buspirone – Buspar |
The chief manufacturer of Buspar is Bristol-Myers Squibb Co. is
commonly referred as BMS is a pharmaceutical corporation founded in
the year 1887 by William Mclaren Bristol and John Ripley Myers. The
company headquarters is located in New York City, New York, USA.
Bristol-Myers Squibb has manufactured and sold the Brand Buspar
under the name Buspirone HCL since 1986. Since the original Buspar
patent had expired the company obtained another patent for anxiety
treatment in the name of metabolite of Buspar. A metabolite is a
substance involved in metabolism i.e. a substance created by the
interaction of the body and the particular drug.
Soon after obtaining the patent rights, the company notified FDA
about manufacturing the generic Buspirone and metabolite. But FDA
permitted only the metabolite to be manufactured. Also the drug
makers prevented the generic version of Buspirone coming into the
market. Later the company sued for the rights to manufacture the
products. The federal court delivered the ruling in favor of the
company saying that they are eligible to manufacture the generic
version of Buspar called Buspirone. However the latest news says
that the ruling of generic Buspirone has been reversed i.e. against
the company and it is at a check that the ability of consumers to
buy the Buspar at a cheaper rate or purchasing a less expensive
version of the drug remains uncertain.
The main thing the company adds is that don’t share the medicine
with others for whom it was not prescribed. It is not advisable to
use it for other health conditions. It should be stored in the room
temperature and kept away from children. A Buspirone (Buspar) tablet
comes in 5 mg, 10 mg, 15 mg, and 30 mg respectively.
|
|
|
|
|
